Effect Of E7090, An Fgfr1-3 Selective Inhibitor, On Resistance To A Cdk4/6 Inhibitor And Endocrine Therapy In Er(+)/Her2(-) Breast Cancer Preclinical Models.
CANCER RESEARCH（2021）
Key words
breast cancer,endocrine therapy,selective inhibitor
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined